evidence

Effectiveness of narrative therapy for depressive symptoms in adults with somatic disorders: A systematic review and meta-analysis - PMC

11 empirical findings extracted from peer-reviewed research.

Source

Effectiveness of narrative therapy for depressive symptoms in adults with somatic disorders: A systematic review and meta-analysis - PMC

View original source | 10407 words | 11 findings extracted

Key Findings

  • The two researchers agreed on 52 out of 54 samples during data screening and coding.

    • 52 out of 54 (N=54)
    • 🟢 Irrefutable | systematic-review

  • The agreement between two researchers during data extraction was high, with 96.30% agreement.

    • 96.30% (N=54)
    • 🟢 Irrefutable | systematic-review

  • The global prevalence of clinical depression is estimated to be 4.4%.

    • 4.4% [2017]
    • 🟡 Strong Signal | government-data

  • The standardized mortality rate for suicide in people with depression is 19.7%.

    • 19.7% [2014]
    • 🟡 Strong Signal | meta-analysis

  • Narrative therapy has a significant effect on depressive symptoms in adults with somatic disorders.

    • SMD = -1.64 (95% CI: -1.95 to -1.32; p <.001) (N=4.9K)
    • 🟡 Strong Signal | meta-analysis

  • Depression is one of the most disabling mental disorders and a top 25 leading cause of global burden in 2019.

    • top 25 leading causes of global burden [2019]
    • 🟡 Strong Signal | government-data

  • In 2017, there were over 340 million people worldwide with clinical depression.

    • more than 340 million [2017]
    • 🟡 Strong Signal | government-data

  • People with depression have almost 20 times the risk of dying by suicide.

    • almost 20 times [2014]
    • 🟡 Strong Signal | meta-analysis

  • Nurses intervening with depressed patients in narrative therapy with an emotional approach appeared effective in improving positive emotions, cognitive-emotional outcomes such as hope, and reducing depressive symptoms.

    • [2015]
    • 🟠 Hypothesis | clinical-trial

  • Narrative therapy was shown to improve depressive symptoms and interpersonal outcomes in adults with major depressive disorder in a one-sample repeated measures design.

    • [2011]
    • 🟠 Hypothesis | longitudinal

  • The prevalence of clinical depression is expected to be the number one disease burden globally in 2030.

    • number one disease burden globally [2030]
    • 🟠 Hypothesis | government-data

Confidence Summary

Tier Count Description
🟢 Irrefutable 2 Meta-analyses, large RCTs, Cochrane reviews
🟡 Strong Signal 6 Multiple studies, large surveys
🟠 Hypothesis 3 Single study, small N, preliminary